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Abstract
The cellular prion protein (PrP
C) plays a fundamental role in prion disease. PrP
C is a glycosylphosphatidylinositol (GPI)-
anchored protein with two variably occupied N-glycosylation sites. In general, GPI-anchor and N-glycosylation direct
proteins to apical membranes in polarized cells whereas the majority of mouse PrP
C is found in basolateral membranes in
polarized Madin-Darby canine kidney (MDCK) cells. In this study we have mutated the first, the second, and both N-
glycosylation sites of PrP
C and also replaced the GPI-anchor of PrP
C by the Thy-1 GPI-anchor in order to investigate the role
of these signals in sorting of PrP
C in MDCK cells. Cell surface biotinylation experiments and confocal microscopy showed
that lack of one N-linked oligosaccharide leads to loss of polarized sorting of PrP
C. Exchange of the PrP
C GPI-anchor for the
one of Thy-1 redirects PrP
C to the apical membrane. In conclusion, both N-glycosylation and GPI-anchor act on polarized
sorting of PrP
C, with the GPI-anchor being dominant over N-glycans.
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Introduction
Prion diseases, occurring in humans and a wide range of
animals, are believed to be caused by misfolding of PrP
C into a
disease-associated form, PrP
Sc [1,2]. PrP
Sc is enriched in b-sheets
and forms partially protease-resistant aggregates which mainly
accumulate in the central nervous system [3].
A multitude of putative physiological functions have been
attributed to PrP
C including control of synaptic activity,
neuroprotection, neurogenesis (reviewed in [4]), maintenance of
myelination [5] or acting as a receptor for b-amyloid oligomers
[6]. Interestingly, although PrP
C is largely conserved between
vertebrates, PrP
C-deficient mice only show subtle phenotypes
[5,7,8].
PrP
C is a glycosylphosphatidylinositol (GPI)-anchored protein
residing in detergent-resistant membranes (DRMs) and removed
from DRMs in order to be internalized via clathrin-coated
endocytosis. DRMs have been postulated as sites of conversion
from PrP
C to PrP
Sc either directly at the cell surface or in the early
endocytic pathway [9]. In addition, divergence or absence of GPI-
anchorage of PrP
C influences development of prion disease
[10,11].
PrP
C is a glycoprotein of 253 amino acids in humans and 254
amino acids in mice that contains two N-glycosylation sites at
Asn
181 and Asn
197 in humans and Asn
180 and Asn
196 in mice.
These sites are variably occupied giving rise to the typical
electrophoretic mobility pattern of di-, mono-, and non-glycosy-
lated polypeptides [12,13,14]. The biological significance of this
complex pattern of glycosylation is not known but mutations in the
consensus sites for glycosylation lead to genetic forms of
Creutzfeldt-Jakob Disease [15,16].
Polarized cells such as neurons or epithelial cells consist of two
specialized plasma membrane domains, the apical and basolateral
membranes. The maintenance of polarity and cellular function
requires distinct differential protein sorting mechanisms and
various signal structures are needed for the selective transport of
membrane proteins to the apical or basolateral membranes. In
general, N-glycosylated and GPI-anchored proteins are apically
sorted when expressed in Madin-Darby canine kidney (MDCK)
epithelial cells. The GPI-anchor can act as an apical signal that is
well conserved among species [17] and chimeric GPI-anchored
proteins are found in the apical compartment [18,19]. However,
addition of the GPI-anchor of T-cadherin to EGFP proved to be
insufficient for apical delivery in MDCK cells [20]. The
unpolarized delivery of GPI-anchored rat growth hormone fusion
protein, could be directed to the apical compartment by the
addition of N-glycans [21] and addition of N-glycans to an
otherwise unpolarized secreted protein directs it to the apical
compartment [22]. Furthermore, mutation of the N-glycosylation
sites of the GPI-anchored membrane dipeptidase protein (MDP)
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form an additional structural element for the sorting of GPI-
anchored proteins to the apical side [24,25].
PrP
C is an exception because it is the only N-glycosylated, GPI-
anchored protein known to date that is basolaterally sorted in
MDCK cells [26]. Signals that regulate basolateral sorting of PrP
C
are not fully understood but elimination or mutations of the
hydrophobic core of PrP
C lead to apical sorting [27], suggesting
sorting determinants in the luminal domain. In contrast, the
transfer of the GPI-anchor signal sequence of PrP
C to EGFP
resulted in basolateral targeting of the EGFP fusion protein [28].
Because the role of glycosylation in sorting of PrP
C is poorly
understood, in this study we investigated the role of N-glycans and
the GPI-anchor as potential polar sorting signals of PrP
C expressed
in MDCK cells. The most striking phenotype was that the loss of a
single N-glycosylation site resulted in sorting to membranes in an
unpolarized manner. In addition, the substitution of the PrP
C-
GPI-anchor by the Thy-1-GPI-anchor, which targets Thy-1 to the
apical compartment, redirected PrP
C to the apical side. These data
suggest that the GPI-anchor represents a dominant basolateral
sorting signal of PrP
C which can be modulated by N-linked
oligosaccharides.
Materials and Methods
cDNA constructs
The cDNA containing the mouse Prnp open reading frame with
the 3F4 mAb epitope tag in pcDNA3.1(+)/Zeo expression vector
was a gift from M. Groschup (Institute for Novel and Emerging
Infectious Diseases at the Friedrich-Loeffler-Institut, Greifswald -
Insel Riems, Germany). Mutations eliminating the consensus site
for N-glycans were made with the QuickChange Site-Directed
Mutagenesis Kit (Stratagene). For the mutation N180Q, the
following primers were used: 59GTGCACGACTGCGTCCA-
AATCACCATCAAGCAG 39 (sense) and 59CTGC TTGAT-
GGTGATTTGGACGCAGTCGTGCAC 39 (antisense). For the
N196Q mutation, the following primers were used: 59GACCAC-
CAAGGGGGAGCAATTCACCGAGACCGATG 39 (sense) and
59CATCGGTCTCGGTGAA TTGCTCCCCCTTGGTGGC
39 (antisense, mutations are in bold). For PrP
C-GPIThy-1, a
fusion PCR approach was used. Thy-1 full length cDNA clone
(IMAGENES) was subcloned into pCDNA 3.1(2)/Neo expression
vector (Invitrogen). The primers used for the fusion PCR were: for
the PrP
C moiety, primer A (sense) 59ACCAGGGATAGCTGC-
GTTTA 39 and primer B (antisense) GCCGCCGGATCTT
CTCCCGTC and for the Thy-1 moiety, primer C (sense)
59GATCCGGCGGCATAAGCCTG 39 and primer D (antisense)
59AAGCTTAGTTCAGGGCCCCAG 39. The resulting DNA
was inserted into pcDNA3(2)/Neo expression vector (Invitrogen)
and all sequences were verified by DNA sequencing.
Cell culture and transfections. MDCK cells [29] were grown in
Dulbecco’s modified Eagle’s medium high glucose with L-
gutamine, supplemented with 10% fetal bovine serum, penicil-
lin/streptomycin (PAA Laboratories) and 25 mM HEPES (Invi-
trogen) in a 5% CO2 incubator. Transfections were made with
Lipofectamine 2000 (Invitrogen) as described by the supplier and
after three weeks under selection media (Zeocin 400 mg/ml
(Invitrogen) or G418 800 mg/ml (PAA Laboratories)) resistant
clones were selected.
DRMs isolation
Confluent cells plated in a 100 mm Petri dish were washed
twice with cold PBS (10 mM phosphate buffered saline pH 7.4)
and scraped in TNE buffer (50 mM Tris-HCl, 150 mM NaCl,
2 mM EDTA, pH 7.4.) with 1% Triton X-100 and EDTA-free
protease inhibitor cocktail (Roche). Cells were disrupted with a
26G needle and incubated for 30 min in an orbital rotor at 4uC.
After centrifugation for 5 min at 500 g, supernatants were mixed
with OPTIPREP (Sigma), to get a final concentration of iodixanol
of 40% and placed in the bottom of a centrifuge tube (UltraClear,
Beckmann). 7.5 ml of 30% iodixanol prepared in TNE buffer and
3.5 ml of 5% iodixanol were sequentially layered on top. After
18 h centrifugation at 155.000 g in an SW40 Ti rotor (L-60
ultracentrifuge, Beckman), 1 ml fractions were taken from the top.
300 ml of each fraction were acetone precipitated, mixed with 46
sample buffer (250 mM Tris-HCl, 8% SDS, 40% glycerol, 20% b-
mercaptoethanol, 0.008% Bromophenol Blue, pH 6.8) and
analysed by western blot. The 3F4 anti-mouse antibody (Covance)
was used at a dilution of 1:1,000 [30] and flotillin anti-mouse
antibody (BD Transduction) was used at a dilution of 1:5,000.
Cell surface biotinylation assays
MDCK cells stably expressing the indicated constructs were
plated at density of 2610
5 in 24 mm polycarbonate 0.4 mm pore
Transwellfilters(Costar)and grownfor4 to5daysuntilpolarization
was achieved. Media was changed every other day. To evaluate
integrity of the monolayer we used the method described by
Lipschutz et al [31], whereby leakiness of the apical fluid is assessed
by observation for 12 to 18 hours. Only in instances where leakiness
of the apical fluid could be excluded, cells were used for further
experiments. For the cell surface biotinylation assay, polarized cells
were washed three times with cold Dulbecco’s PBS (DPBS, Sigma-
Aldrich) containing CaCl2 and MgCl2 (used in all the experiments)
and incubated either apically or basolaterally with EZ-Link Sulfo-
NHS-SS-Biotin (Thermo Scientific) in DPBS for 30 min at 4uC
while shaking. The reaction was stopped by adding Quenching
Solution (Pierce) and extensively washed with TBS (10 mM Tris-
HCl pH 7.4, 140 mM NaCl). Membranes were then excised and
placed in 1.5 ml tubes containing 500 ml of lysis buffer (25 mM
Tetra-Ethyl-Ammonium-chloride (TEA.Cl) pH 8.1, containing
2.5 mM EDTA, 50 mM NaCl, 0.25% SDS and 1.25% Triton X-
100) with EDTA-free protease inhibitor cocktail (Roche). After
incubation for 1 h at 4uC, samples were centrifuged at 12,000 g for
5 min and supernatants were further incubated with High Capacity
Neutravidin Agarose beads (Thermo Scientific) in Spin Columns
(Pierce) for 1 h at room temperature. After washing extensively with
wash buffer (20 mM TEA.Cl pH 8.6, containing 150 mM NaCl,
5 mMEDTA,1%Triton-X100 and 0.2%SDS) followed bywashes
with TBS wash buffer without detergents, proteins were eluted by
boiling for 5 min with 46sample buffer. Following electrophoresis,
Western blots were incubated with 3F4 antibody as described above
and anti-mouse E-Cadherin (BD Transduction) at a dilution of
1:5,000. After washing with TBST (TBS containing 0.1% Tween-
20), secondary anti-mouse or anti-rabbit antibodies (Promega) were
used at a dilutionof 1:1,000. Blots weredeveloped with SuperSignal
West Pico or West Femto Chemiluminiscent Substrate (Thermo
Scientific) in a CD camera imaging system (BioRad). Quantification
of at least three independent experiments was made by using
Quantity One analysis software (BioRad).
Confocal immunofluorescence microscopy
Cells plated in 12 mm polycarbonate Transwell filters for 4 to 5
days were placed on ice and washed twice with cold DPBS,
incubated with the 3F4 anti-mouse antibody at a dilution of 1:100
in DPBS with 2% of normal donkey serum (Dianova). After
20 min incubation at 4uC, cells were washed three times in cold
DPBS and incubated for 20 min with secondary donkey anti-
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normal donkey serum at 4uC. After three washes with cold DPBS,
cells were fixed with 4% paraformaldehyde in PBS for 10 min at
room temperature and extensively washed. DAPI (Roche) was
added in the last wash and incubated for 5 min in order to
visualize nuclei. Filters were cut out and placed cell side up in a
microscope slide containing a drop of Fluoromount G (South-
ernBiotech) mounting media. For double-immunocytochemistry
with 3F4 anti-mouse antibody and rabbit anti-ZO-1 antibody
(Invitrogen), the procedure described above for the 3F4 antibody
staining was performed first. Then, after fixation with parafor-
maldehyde and washes with DPBS, cells were incubated for
10 min with DBPS containing 0.1% Triton X-100. Washes
between the incubation with primary and secondary antibodies
were also performed with DPBS containing 0.1% Triton X-100.
Cells were incubated with ZO-1 antibody, used at a dilution of
1:100 in DPBS containing 2% of normal donkey serum, for
20 min at room temperature. After washing with DPBS
containing 0.1% Triton X-100, secondary donkey anti-rabbit
antibody AlexaFluor555 (Invitrogen) was diluted in DPBS
containing 2% of normal donkey serum and incubated for
20 min at room temperature. After extensive washing with DPBS,
DAPI was added in the last wash and samples were mounted as
described before. For 3F4 antibody staining under permeabilizing
conditions, the same procedure as used for the ZO-1 staining was
performed. Consecutive Z-stacks were taken with Leica Laser
Scanner Confocal Microscope TCS SP2 (Leica) and images were
further processed with the Volocity 5 Software (Perkin Elmer).
Results
Lack of glycosylation does not alter plasma membrane
localization of PrP
C
One of the purposes of our study was to determine the role of the
glycans in sorting of mouse PrP
C. We therefore generated stably
expressing PrP
C mutants in which the first (N180Q mutant,
PrP
CG1),thesecond(N196Qmutant, PrP
CG2), andboth (N180Q/
N196Q mutant, PrP
CG3) consensus sites for N-glycosylation
were changed. The corresponding PrP
C represented mono- or
non-glycosylated PrP
C in MDCK cells (Fig. 1). PrP
C glycomutants
and wild-type PrP
C (PrP
CWT) contained the 3F4 epitope tag
allowing discrimination of overexpressed from endogenous PrP
C
[32]. Clones with similar PrP
C expression levels were chosen for the
study (Fig. 2A). Western blots showed that in extracts of PrP
CWT
expressing cells the typical PrP
C glycosylation pattern was detected
with polypeptides of an approximate size of 34, 29, and 24 kDa. No
immunoreaction was observed innon-transfected cells.PrP
CG1and
G2 polypeptides showed two bands at 29 and 24 kDa whereas
PrP
CG3 represented a single band at 24 kDa.
In order to assess whether mouse PrP
C lacking N-glycans is
correctly localized at the plasma membrane, we used confocal
fluorescence microscopy of cells grown in Transwells. Under non-
permeabilising conditions, PrP
CG1, G2, G3, and PrP
CWT were
found to be present at the plasma membrane. When cells were
permeabilised, non-glycosylated PrP
CG3 showed the most intense
intracellular labeling whereas PrP
CG2 was mainly localized at the
plasma membrane and PrP
CG1 and PrP
CWT could be found both
at the plasma membrane and in intracellular membranes (Fig. 2B).
Since PrP
C is largely located in defined DRMs, we assessed
distribution of PrP
CWT and PrP
CG1, G2, and G3 in insoluble
fractions after Triton X-100 extraction and sucrose density
gradient centrifugation. All glycomutants expressed in MDCK
cells were correctly located in DRMs with patterns similar to
PrP
CWT (Fig. 2C).
Monoglycosylated PrP
C sorts in an unpolarized manner in
MDCK cells
To determine whether glycosylation affects the sorting of PrP
C
in polarized cells, the expression at apical and basolateral
membranes of mutant PrP
CG1 to G3 in filter-grown MDCK
cells was studied by immunofluorescence microscopy. ZO-1
antibody, labeling the tight junctions that separate apical from
basolateral membrane [33], was used in order to verify full cell
polarization (Fig. 3A). PrP
CWT and PrP
CG3 were mainly found in
the basolateral compartment whereas PrP
CG1 and PrP
CG2 were
found to be present both, in apical and the basolateral
compartments (Fig. 3B).
In order to quantify PrP
C at the plasma membrane at steady
state, cell surface biotinylation experiments of filter-grown MDCK
cells were performed. E-cadherin served as a marker for the
basolateral compartment [34] and was highly concentrated at the
basolateral side (average of 94%, SEM 60.76). Half of the total
PrP
CG1 and PrP
CG2 were found at the apical and basolateral
membrane (PrP
CG1, 49%67.6 basolateral, 51%67.6 apical;
PrP
CG2 46%611.8 basolateral, 54%611.8 apical). PrP
CG3 was
enriched at the basolateral membrane, comparable to PrP
CWT
(PrP
CWT, 74.1%66.7 basolateral, 25.9%66.7 apical; PrP
CG3,
74%64.8 basolateral, 26%64.8 apical) (Fig. 4).
Thy-1 GPI-anchor directs PrP
C to the apical membrane in
MDCK cells
PrP
C is a GPI-anchored protein. The fact that it is concentrated
at the basolateral compartment in MDCK cells raises the question
of the role of its GPI-anchor in sorting. Therefore, we stably
expressed a fusion protein, comprising mouse PrP
C with the GPI-
anchor signal sequence of Thy-1 (PrP
C-GPIThy-1) in MDCK cells
(Fig. 5A). Thy-1 is neuronally expressed and, like PrP
C, found in
DRMs but it is exclusively targeted to the apical compartment
[35].
Cell clones with similar expression levels of PrP
C and PrP
C-
GPIThy-1 were chosen for further analysis (Fig. 5B). Western blot
Figure 1. Schematic drawing of constructs used in this study.
Shown are the maps of PrP
CWT, PrP
CG1, PrP
CG2, and PrP
CG3 with N-
terminal signal sequence (ss) and C-terminal GPI-anchor signal (ss GPI-
anchor) (dark boxes) and the mutations introduced to delete N-
gylcosylation sites.
doi:10.1371/journal.pone.0024624.g001
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C-GPIThy-1 and
PrP
C, with a prominent diglycosylated band in both cases. To
exclude that the addition of the Thy-1 GPI-anchor affects
intracellular transport, immunofluorescence microscopy under
non-permeabilising conditions was performed. This showed
localization and integration of PrP
C-GPIThy-1 at the plasma
membrane (Fig. 5D). In contrast to neurons, we could not detect
shedded forms of PrP
C and PrP
C-GPIThy-1 in the media (data not
shown) indicating no substantial shedding in MDCK cells [36].
Triton X-100 extraction and sucrose density gradient centrifuga-
tion showed that PrP
C-GPIThy-1, like PrP
C, can be recovered in
flotillin enriched DRM fractions (Fig. 5E). Confocal microscopy of
cells grown in Transwells showed that PrP
C-GPIThy-1 was mainly
present in the apical compartment separated from the basolateral
side by ZO-1 immunoreactive tight junctions (Fig. 6A and B). Cell
surface biotinylation confirmed data of morphological analysis
with PrP
C-GPIThy-1 being mainly found in apical membranes
(37.7%61.5 basolateral, 62.3%61.5 apical) (Fig. 6C).
Discussion
In this study we investigated the role of the N-glycans and the
GPI-anchor in polarized sorting of mouse PrP
C to gain deeper
insight into the physiological function of PrP
C and into the
pathophysiology of prion disease [11,37,38]. Under physiological
conditions, the occupancy of the N-glycosylation sites at N180 and
N196 of PrP
C is variable and cell dependent [39,40]. In human
brain, full length as well as truncated forms with variable
glycosylation content are found [13] suggesting proper folding of
all glycoforms [41].
Changes of Asn residues at codon 180 and 196 of PrP
C alter N-
glycosylation without affecting cell surface expression of PrP
C or
conversion to PrP
Sc [42,43], whereas mutations of the Thr
residues of the N-glycosylation consensus site Asn-X-Thr, that also
eliminate the N-glycosylation, disturb intracellular trafficking
[42,43,44,45]. For our study we chose to eliminate N-glycosylation
by substitution of Asn by Gln in both consensus sites (N180Q,
N196Q) because our aim was to express all three glycoforms at the
plasma membrane. All the glycomutants (N180Q, N196Q, and
N180Q/ N196Q) used in our study were correctly inserted in lipid
rafts at the plasma membrane. When permeabilised, however, we
could observe an increased intracellular staining intensity for
PrP
CG3, indicating that non-glycosylated PrP
C is retained in
intracellular membranes, most likely in the ER as previously
described [41].
In our study we found that 74% of mouse PrP
C is present at the
basolateral membrane of MDCK cells, in agreement with previous
studies [26,27]. Why human PrP
C is selectively targeted to the
apical side in MDCK and Caco2 intestinal cells [46] is unclear.
However, our data clearly show that the presence of only one N-
glycanleads to unpolarized sorting whereasnon-glycosylated mouse
PrP
C is sorted, like wild-type PrP
C, to the basolateral membrane. N-
glycans have been postulated as one of the main apical targeting
signals for polarized sorting of membrane proteins. Thus, GPI-
anchored glycosylated membrane dipeptidase (MDP) is targeted to
theapicalmembranewhereasthenon-glycosylated MDPwasfound
Figure 2. Physiological membrane localization of PrP
C glyco-
mutants. (A) Characterization of glycomutants (PrP
CG1, PrP
CG2, and
PrP
CG3) and PrP
CWT for the study by Western blot analysis, using an
antibody directed against the 3F4 epitope. Clones with similar amounts
of overexpressed 3F4 tagged PrP
C as assessed by densitometric analysis
of Western blots were used for these analyses (see graph). Relative
expression of various PrP
C forms is shown in percentages of PrP
CWT
that was set to 100%. (B) Assessment of plasma membrane (non-
permeabilized) and intracellular (permeabilized) localization of PrP
C
glycomutants by confocal microscopy shows presence of PrP
C at the
plasma membrane and intracellularly (scale bar is 10 mm). (C)
Assessment of DRMs localization of PrP
C glycomutants by Triton X-
100 extraction at 4uC and sucrose density gradient centrifugation
showing correct localization of PrP
C glycomutants with flotillin-positive
DRM containing fractions.
doi:10.1371/journal.pone.0024624.g002
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secreted in an unpolarized manner such as the rat growth hormone,
are apically secreted after introduction of N-glycosylation sites [21].
Furthermore, the basolateral expression of Na,K ATPase B1
subunitinMDCKcellsisaltered and directedtothe apicalsideafter
addition of mutagenesis-mediated N-glycosylation. The apical
targeting is correlated to the extent of N-glycosylation [47].
Surprisingly, we found that the loss of one N-linked oligosac-
charide either at N180 or N196 leads to an equal localization of
PrP
C both at the apical and basolateral membrane in steady state.
Similar observations have been reported by Sarnataro et al. [26]
showing that the wild type PrP
C is transported first to both
membrane sides of MDCK cells followed by accumulation of PrP
C
at the basolateral membrane within 120 min. The authors
explained the transient expression of PrP
C at the apical membrane
by selective clearance or by internalization of apically expressed
PrP
C and subsequent transcytosis to the basolateral side. Selective
clearance or transcytosis are unlikely to explain the unpolarized
distribution of monoglycosylated PrP
C because of the extracellular
orientation of PrP
C oligosaccharide chains. Therefore, it is possible
that the affinity or specificity of monoglycosylated PrP
C for
binding to distinct lectins such as galectins 3 or 9 [48,49] required
for transport along the secretory pathway and/or sorting in the
Golgi apparatus, are altered in comparison of wild type PrP
C.
More than 30 different types of glycan chains have been
identified by mass spectrometry to attach PrP
C. Glycans attached
at position N180 of mouse PrP
C have a lower proportion of tri-
and tetra-antennary glycans and oligosaccharides at position N196
are more complex and acidic [50]. Molecular dynamic simulation
of fully glycosylated human PrP
C showed that glycosylation at
N181 plays a functional role, whereas glycosylation at N197,
where the protein is more unstructured, plays a role in stabilization
[51]. How the structure of monoglycosylated PrP
C is changed
following the loss of one N-linked oligosaccharide, and its effect on
lectin recognition in the ER deserves further studies.
Of interest, glycosylation patterns in the retina (comparable to
the basolateral compartment) and the optic nerve (comparable to
the apical compartment) differ in species with altered susceptibilty
towards prion infection [52]. Recent data indicate that prion
infection is a polarized event affected by glycosylation of PrP
C.
When PrP
C is not expressed in the compartment that is in contact
with infectious prions, cells are not infected [53,54]. Our data
Figure 3. N-glycosylation of PrP
C affects polar sorting in MDCK
cells. MDCK cells stably expressing PrP
CWT, PrP
CG1, PrP
CG2 or PrP
CG3
were grown in Transwells for 4 to 5 days until they were fully polarized.
(A) Cells were separately stained with the 3F4 antibody (green) followed
by permeabilisation and staining with an antibody against ZO-1 (red), a
constituent of tight junctions, indicating the cell polarity. Confocal
microscopy of a Z-stack of PrP
CWT (left) at the level of tight junctions
stained with ZO-1, and YZ-sections (right) of all glycomutants indicate
both the integrity of the polarized monolayer and a redistribution of
PrP
CG1 and PrP
CG2 to the apical compartment when compared to
PrP
CWT and PrP
CG3. Localization of the apical (a) and basolateral (b)
compartment is indicated. (B) After immunocytochemistry under non-
permeabilising conditions with the 3F4 antibody, serial Z-stacks from
the bottom to the top were taken with confocal microscopy. YZ images
shows transversal cut trough cells at the mid level, marked with a
dashed line. PrP
CWT and PrP
CG3 were mainly found in the basolateral
compartment whereas PrP
CG1 and PrP
CG2 were mainly found in both
compartments. Scale bars represent 10 mm.
doi:10.1371/journal.pone.0024624.g003
Figure 4. Cell surface biotinylation assay confirms a role of the
N-glycans in polarized sorting of PrP
C. Cells were grown in
Transwells for 4–5 days until fully polarized and labelled with EZ-Link
Sulfo-NHS-SS-Biotin either on the apical (a) or the basolateral (b) side.
Cells were processed for PrP
C (recognized with the 3F4 antibody) and E-
cadherin Western blotting in parallel. The graph indicates densitometric
evaluation of Western blots of at least 3 independent experiments,
expressed as mean percentages 6 SEM apical (a) or basolateral (b) of
total protein found, which is set at 100%.
doi:10.1371/journal.pone.0024624.g004
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C-GPIThy-1 is glycosylated and transported to the
plasma membrane. (A) Schematic presentation of GPI-anchored
PrP
CWT and the PrP
C fusion protein with the GPI-anchor of Thy-1
(PrP
C-GPIThy-1). The substitution of the GPI-anchor signal sequence
(ss) of the PrP for the one of Thy-1 is indicated. (B) Western blots of
PrP
CWT and PrP
C-GPIThy-1 stably expressed in MDCK cells. A clone
with a similar expression level as PrP
CWT was chosen. The glycotype of
di-, mono-, and non-glycosylated PrP
C-GPIThy-1 is unchanged. (C)
Assessment of non-permeabilized membrane localization of PrP
CWT
and PrP
C-GPIThy-1 by confocal microscopy shows plasma membrane
localization of both proteins (scale bar is 10 mm). (D) Sucrose density
gradient centrifugation of 1% Triton-X100 extraction at 4uCo fP r P
CWT
and PrP
C-GPIThy-1 cells reveal localization of both in flotillin enriched
DRMs. Fractions were taken from the top (fraction 1) to the bottom
(fraction 12).
doi:10.1371/journal.pone.0024624.g005
Figure 6. Thy-1-GPI anchor redirects PrP
C to the apical site. (A)
Cells stably expressing PrP
CWT and PrP
C-GPIThy-1 were grown in Transwells
for 4 to 5 days, processed for immunocytochemistry, and analyzed with
confocal microscopy. YZ sections (left) and view on the membrane (right) at
the level of tight junctions stained for ZO-1 (red) confirm both polarization
and confluency of cells and show increased apical signal for PrP
C-GPIThy-1
(green). (B) After staining with PrP 3F4 antibody under non-permeabilizing
conditions, serial Z-stacks from the bottom to the top were taken. YZ
sections show transversal cut through cells at the level of the dashed line in
mid. PrP
C-GPIThy-1 was found at the apical membrane when compared to
PrP
CWT. Scale bars are 10 mm. (C) Cells grown in Transwells labeled with EZ-
Link Sulfo-NHS-SS-Biotin either apically (a) or basolaterally (b) were
processed for Western blotting for PrP
C and E-Cadherin (as control of cell
polarization) in parallel. The graph (three independent experiments) shows
mean percentages 6 SEM of apical (a) or basolateral (b) amount of protein
when compared to the total amount which is set at 100%.
doi:10.1371/journal.pone.0024624.g006
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PrP
C will be more prone to infection, due to the equal distribution
in both the apical and basolateral compartment.
Furthermore, we show that the GPI-anchor functions as a
strong polarity signal for PrP
C. Chimeric PrP
C-GPIThy-1 shows (i)
a PrP
CWT-like glycosylation pattern, (ii) an expression at the
plasma membrane, and (iii) localization in DRMs. The redirection
of PrP
C-GPIThy-1 to the apical compartment, however, demon-
strates the dominance of the GPI-anchor over N-glycosylation. At
present, the molecular mechanism of sorting to different
membranes between PrP
C and PrP
C-GPI Thy-1 is unclear. It is
known that the GPI-anchor affects protein structure and/or its
interactions with the cell membrane [55]. In addition, the glycan
moiety of the Thy-1 GPI-anchor that contains less complex sugar
side chains than the PrP
C GPI-anchor, can occupy a carbohydrate
binding site of the protein domain [56]. Finally, there are reports
showing that although Thy-1 and PrP
C are DRM residents, they
occupy domains that differ in their lipid composition [28,57,58].
The differential sorting can also be observed in neurons, where
PrP
C is more enriched in the cell body and Thy-1 in neurites. [58].
Additionally, a hydrophobic core region in the ectodomain has
been described that mediates basolateral sorting of PrP
C and leads
to apical missorting upon site-directed mutagenesis [27]. These
data and the results of our study indicate that PrP
C contains at
least two independent signal structures, in the hydrophobic core
and the GPI-anchor, directing PrP
C to the basolateral membrane.
A third modulatory sorting motif is presented by the number of N-
linked oligosaccharids in PrP
C.
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